"Folic Acid-Chitosan Conjugated Mesoporous Silica Nanoparticles for Enhanced Piceatannol Uptake in MCF-7 Breast Cancer Cells"
Google Scholar Citations
Scopus Citations
WoS Researcher ID
Orcid ID
CITATION
Cutting-edge advancements in anticancer drug delivery and scope for theranostics using biocompatible multifunctional mesoporous silica nanoparticles, S. Sarnaik, D. Bhatane, S.R. Pamshong, A. Alexander, Journal of Drug Delivery Science and Technology, 94 (2024) 105504. (Impact Factor: 4.5)
Mesoporous silica nanoparticles: An emerging approach in overcoming the challenges with oral delivery of proteins and peptides, S.R. Pamshong, D. Bhatane, S. Sarnaik, A. Alexander*, Colloids and Surfaces B: Biointerfaces, 232 (2023) 113613. (Impact Factor: 4.5)
Potential applications of mesoporous silica nanoparticles for the treatment of neurological disorders, D. Bhatane, S.R. Pamshong, S. Sarnaik, P. A, A. Alexander*, Journal of Drug Delivery Science and Technology, 89 (2023) 104970. (Impact Factor: 4.5)
Overcoming skin barriers through advanced transdermal drug delivery approaches, V. Phatale, K.K. Vaiphei, S. Jha, D. Patil, M. Agrawal, A. Alexander*, Journal of Controlled Release, 351 (2022) 361-380. (Impact Factor: 10.5)
PCL-PEG copolymer based injectable thermosensitive hydrogels, M.R. Dethe, P. A, H. Ahmed, M. Agrawal, U. Roy, A. Alexander*, Journal of Controlled Release, 343 (2022) 217-236. (Impact Factor: 10.5)